1) Shirasaka T, Shimamoto Y, Ohshimo H et al Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 7: 548-557, 1996
3) Esmaeli B, Golio D, Lubecki L et al : Canalicular and nasolacrimal duct blockage : an ocular side effect associated with the antineoplastic drug S-1. Am J Ophthalmol 140 : 325-327,2005